Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human GFR alpha-3/GDNF R alpha-3 Antibody, R&D Systems™

Goat Polyclonal Antibody
Supplier: R&D Systems AF670SP
This item is not returnable.
View return policy
Description
GFR alpha-3/GDNF R alpha-3 Polyclonal specifically detects GFR alpha-3/GDNF R alpha-3 in Human samples. It is validated for Western Blot, Immunohistochemistry.Specifications
GFR alpha-3/GDNF R alpha-3 | |
Polyclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
GDNF family receptor alpha 3, GDNF family receptor alpha-3, GDNF R alpha-3, GDNF receptor alpha-3, GDNFR-alpha-3, GFR alpha3, GFRa-3, GFRA3, GFR-alpha-3, glial cell line-derived neurotrophic factor receptor alpha-3, GPI-linked receptor | |
Goat | |
Affinity Purified | |
RUO | |
2676 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Western Blot, Immunohistochemistry | |
LYOPH | |
Western Blot 0.2 ug/mL, Immunohistochemistry 5-15 ug/mL | |
AAC24355 | |
GFRA3 | |
S. frugiperda insect ovarian cell line Sf 21-derived recombinant human GFR alpha-3/GDNF R alpha-3 Met1-Trp382 Accession # AAC24355 | |
25 μg | |
Primary | |
Detects human GFR alpha-3/GDNF R alpha-3 in direct ELISAs and Western blots. In direct ELISA and Western blots, no cross-reactivity with recombinant human GFR alpha-2 is observed. | |
Human | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction